Guillermo Bastida

Summary

Publications

  1. ncbi [Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease]
    Guillermo Bastida Paz
    Servicio de Medicina Digestiva Hospital Universitario La Fe Valencia España
    Gastroenterol Hepatol 30:511-6. 2007
  2. pmc The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients
    Guillermo Bastida
    Gastroenterology Unit, La Fe Hospital, Valencia, 21 Campanar Avenue, Valencia 46009, Spain
    BMC Gastroenterol 10:26. 2010
  3. ncbi Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease
    G Bastida
    Gastroenterology Unit, La Fe Hospital, Valencia, Spain
    Aliment Pharmacol Ther 22:775-82. 2005
  4. ncbi Evaluation of postsurgical recurrence in Crohn's disease: a new indication for capsule endoscopy?
    Vicente Pons Beltrán
    Gastroenterology Unit, La Fe University Hospital, Valencia, Spain
    Gastrointest Endosc 66:533-40. 2007
  5. ncbi On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction
    Julio Ponce
    Gastroenterology Unit, La Fe University Hospital, Valencia, Spain
    Dig Dis Sci 49:931-6. 2004
  6. doi Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)
    Mariam Aguas
    Gastroenterology Dept La Fe University Hospital, Valencia, Spain
    J Crohns Colitis 5:227-33. 2011
  7. pmc Small intestinal bacterial overgrowth in inactive Crohn's disease: influence of thiopurine and biological treatment
    Cristina Sánchez-Montes
    Cristina Sánchez Montes, Vicente Ortiz, Guillermo Bastida, Ester Rodríguez, María Yago, Belén Beltrán, Mariam Aguas, Marisa Iborra, Vicente Garrigues, Julio Ponce, Pilar Nos, Gastroenterology Unit, Hospital Universitari I Politècnic La Fe, 46026 Valencia, Spain
    World J Gastroenterol 20:13999-4003. 2014
  8. ncbi Outcome of patients with nonstenotic, nonfistulizing Crohn's disease
    Pilar Nos
    Hospital La Fe, Valencia, Spain
    Dig Dis Sci 49:1771-6. 2004
  9. pmc Septic thrombophlebitis of the superior mesenteric vein and multiple liver abscesses in a patient with Crohn's disease at onset
    Mariam Aguas
    Gastroenterology Department, Hospital La Fe, Avenida Campanar, Valencia, Spain
    BMC Gastroenterol 7:22. 2007
  10. doi Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease
    Belen Beltran
    Department of Gastroenterology, Hospital Universitari La Fe, Valencia, Spain
    Inflamm Bowel Dis 16:76-86. 2010

Collaborators

Detail Information

Publications15

  1. ncbi [Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease]
    Guillermo Bastida Paz
    Servicio de Medicina Digestiva Hospital Universitario La Fe Valencia España
    Gastroenterol Hepatol 30:511-6. 2007
    ..There is limited information on the optimal use of thiopurinic immunomodulators in inflammatory bowel disease (IBD) and the dosage, efficacy and toxicity of these drugs has not been clearly established...
  2. pmc The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients
    Guillermo Bastida
    Gastroenterology Unit, La Fe Hospital, Valencia, 21 Campanar Avenue, Valencia 46009, Spain
    BMC Gastroenterol 10:26. 2010
    ..The aims were to evaluate the HRQoL in patients with IBD treated with thiopurines and assess the short- and long-term impacts of the treatment on HRQoL...
  3. ncbi Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease
    G Bastida
    Gastroenterology Unit, La Fe Hospital, Valencia, Spain
    Aliment Pharmacol Ther 22:775-82. 2005
    ..The incidence of thiopurine-induced hepatotoxicity in patients with inflammatory bowel disease varies in different studies...
  4. ncbi Evaluation of postsurgical recurrence in Crohn's disease: a new indication for capsule endoscopy?
    Vicente Pons Beltrán
    Gastroenterology Unit, La Fe University Hospital, Valencia, Spain
    Gastrointest Endosc 66:533-40. 2007
    ..Recurrence after surgery to treat Crohn's disease is frequent and unpredictable. The efficacy of postsurgery capsule endoscopy in detecting recurrence in patients with Crohn's disease is yet to be confirmed...
  5. ncbi On-demand therapy with rabeprazole in nonerosive and erosive gastroesophageal reflux disease in clinical practice: effectiveness, health-related quality of life, and patient satisfaction
    Julio Ponce
    Gastroenterology Unit, La Fe University Hospital, Valencia, Spain
    Dig Dis Sci 49:931-6. 2004
    ..On-demand therapy is useful for the clinical management of patients with mild GERD, allowing adequate symptoms control, limiting PPI consumption, and affording important patient satisfaction with normalization of HRQoL...
  6. doi Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)
    Mariam Aguas
    Gastroenterology Dept La Fe University Hospital, Valencia, Spain
    J Crohns Colitis 5:227-33. 2011
    ..However, it is not known whether relatives of patients with IBD have a greater prevalence of IBS than the general population...
  7. pmc Small intestinal bacterial overgrowth in inactive Crohn's disease: influence of thiopurine and biological treatment
    Cristina Sánchez-Montes
    Cristina Sánchez Montes, Vicente Ortiz, Guillermo Bastida, Ester Rodríguez, María Yago, Belén Beltrán, Mariam Aguas, Marisa Iborra, Vicente Garrigues, Julio Ponce, Pilar Nos, Gastroenterology Unit, Hospital Universitari I Politècnic La Fe, 46026 Valencia, Spain
    World J Gastroenterol 20:13999-4003. 2014
    ..To investigate the influence of thiopurines and biological drugs on the presence of small intestinal bacterial overgrowth (SIBO) in patients with inactive Crohn's disease (CD)...
  8. ncbi Outcome of patients with nonstenotic, nonfistulizing Crohn's disease
    Pilar Nos
    Hospital La Fe, Valencia, Spain
    Dig Dis Sci 49:1771-6. 2004
    ..The inflammatory pattern of CD remains stable in about half of patients. The course of this pattern is not indolent, however, since the needs for immunosuppression and surgical resection during follow-up are considerable...
  9. pmc Septic thrombophlebitis of the superior mesenteric vein and multiple liver abscesses in a patient with Crohn's disease at onset
    Mariam Aguas
    Gastroenterology Department, Hospital La Fe, Avenida Campanar, Valencia, Spain
    BMC Gastroenterol 7:22. 2007
    ....
  10. doi Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease
    Belen Beltran
    Department of Gastroenterology, Hospital Universitari La Fe, Valencia, Spain
    Inflamm Bowel Dis 16:76-86. 2010
    ..In addition, mitochondrial function (DeltaPsim) was analyzed to detect the possible origin of ROS...
  11. ncbi Constipation during pregnancy: a longitudinal survey based on self-reported symptoms and the Rome II criteria
    Julio Ponce
    Gastroenterology Unit, Hospital Universitari La Fe, Valencia, Spain
    Eur J Gastroenterol Hepatol 20:56-61. 2008
    ..The prevalence of constipation during pregnancy and puerperium is similar to that recorded among the female population from the same geographic area...
  12. doi Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients
    Maria Chaparro
    Gastroenterology Unit, La Princesa and Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
    Inflamm Bowel Dis 19:1404-10. 2013
    ..To evaluate the safety of thiopurines in patients with inflammatory bowel disease. To identify predictive factors associated with the development of thiopurine-induced adverse events...
  13. ncbi Manifestations of gastroesophageal reflux and response to omeprazole therapy in patients with chronic posterior laryngitis: an evaluation based on clinical practice
    Vicente Garrigues
    Gastroenterology Unit, Hospital La Fe, Valencia, Spain
    Dig Dis Sci 48:2117-23. 2003
    ..In conclusion, patients with posterior laryngitis frequently present with manifestations of gastroesophageal reflux. Response to therapy can not be predicted with certainty...
  14. doi Telemedicine in inflammatory bowel disease: opportunities and approaches
    Mariam Aguas Peris
    Health Research Institute La Fe University Hospital, Valencia, Spain CIBEREHD Networked Biomedical Research Center for Hepatic and Digestive Diseases, Valencia, Spain Department of Gastroenterology, La Fe University and Polytechnic Hospital, Valencia, Spain Morales Meseguer Hospital, Murcia, Spain Instituto de Aplicaciones de las Tecnologías de la Información y Comunicaciones Avanzadas ITACA, Politechnic University, Valencia, Spain Telemedicine Unit, La Fe University and Politechnic Hospital, Valencia, Spain and Red de Investigación en Servicios de Salud en Enfermedades Crónicas REDISSEC, Valencia, Spain
    Inflamm Bowel Dis 21:392-9. 2015
    ..Further studies with large sample sizes and complex diseases are needed to confirm these results...
  15. ncbi [Factors influencing the decision to administer systemic corticosteroids in Crohn's disease]
    P Nos
    Servicio de Medicina Digestiva, Hospital La Fe, Valencia, Spain
    Gastroenterol Hepatol 27:444-9. 2004
    ..The objective of this study is to determine which clinical and laboratory parameters are associated with the therapeutic decision to administer corticosteroids during the course of the disease...